Considering that carriers of SUPT5H variants have a hematological phenotype comparable to that of beta-thalassemia carriers, the expected phenotypic expression of double heterozygotes is more severe, which seems to be confirmed by the hematologic data. This evidence concerns the gene SUPT5H and beta thalassemia.